123 related articles for article (PubMed ID: 35093459)
1. Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid.
Tomono T; Yagi H; Kanemoto S; Ukawa M; Miyata K; Shigeno K; Sakuma S
Int J Pharm; 2022 Mar; 616():121519. PubMed ID: 35093459
[TBL] [Abstract][Full Text] [Related]
2. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
[TBL] [Abstract][Full Text] [Related]
3. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer.
Yagi H; Tomono T; Handa Y; Saito N; Ukawa M; Miyata K; Shigeno K; Sakuma S
Mol Pharm; 2023 Jan; 20(1):303-313. PubMed ID: 36484773
[TBL] [Abstract][Full Text] [Related]
4. Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides.
Tomono T; Yagi H; Igi R; Tabaru A; Fujimoto K; Enomoto K; Ukawa M; Miyata K; Shigeno K; Sakuma S
Int J Pharm; 2023 Nov; 647():123499. PubMed ID: 37832700
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
Ukawa M; Tanishita S; Yagi H; Yoshida Y; Tomono T; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
Mol Pharm; 2019 Mar; 16(3):1105-1118. PubMed ID: 30715891
[TBL] [Abstract][Full Text] [Related]
6. Oligoarginine-linked polymers as a new class of penetration enhancers.
Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
Miyata K; Ukawa M; Mohri K; Fujii K; Yamada M; Tanishita S; Higashitarumi S; Ishizaki S; Kumagai H; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Kobayashi H; Sakuma S
Bioconjug Chem; 2018 May; 29(5):1748-1755. PubMed ID: 29648441
[TBL] [Abstract][Full Text] [Related]
8. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
Takayama K
Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
[TBL] [Abstract][Full Text] [Related]
9. A novel approach using functional peptides for efficient intestinal absorption of insulin.
Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities.
Mohri K; Miyata K; Egawa T; Tanishita S; Endo R; Yagi H; Ukawa M; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
Chem Pharm Bull (Tokyo); 2018; 66(4):375-381. PubMed ID: 29607903
[TBL] [Abstract][Full Text] [Related]
11. Coiled-Coil-Mediated Activation of Oligoarginine Cell-Penetrating Peptides.
Bode SA; Kruis IC; Adams HP; Boelens WC; Pruijn GJ; van Hest JC; Löwik DW
Chembiochem; 2017 Jan; 18(2):185-188. PubMed ID: 27870530
[TBL] [Abstract][Full Text] [Related]
12. Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.
Tanishita S; Ukawa M; Tomono T; Yoshida Y; Tsujioka T; Miyata K; Tobita E; Uto T; Baba M; Sakuma S
Bioconjug Chem; 2019 Dec; 30(12):3028-3037. PubMed ID: 31738536
[TBL] [Abstract][Full Text] [Related]
13. Potential of single cationic amino acid molecule "Arginine" for stimulating oral absorption of insulin.
Kamei N; Khafagy ES; Hirose J; Takeda-Morishita M
Int J Pharm; 2017 Apr; 521(1-2):176-183. PubMed ID: 28223245
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Intracellular Delivery of NuBCP-9 by Conjugation with Oligoarginines Peptides in MDA-MB-231 Cells.
Wang W; Suga T; Hagimori M; Kuroda N; Fuchigami Y; Kawakami S
Biol Pharm Bull; 2018; 41(9):1448-1455. PubMed ID: 30175779
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
16. The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell-penetrating peptide.
Bánóczi Z; Keglevich A; Szabó I; Ranđelović I; Hegedüs Z; Regenbach FL; Keglevich P; Lengyel Z; Gorka-Kereskényi Á; Dubrovay Z; Háda V; Szigetvári Á; Szántay C; Hazai L; Tóvári J; Hudecz F
J Pept Sci; 2018 Oct; 24(10):e3118. PubMed ID: 30084214
[TBL] [Abstract][Full Text] [Related]
17. Chemical and biological investigations of beta-oligoarginines.
Seebach D; Namoto K; Mahajan YR; Bindschädler P; Sustmann R; Kirsch M; Ryder NS; Weiss M; Sauer M; Roth C; Werner S; Beer HD; Munding C; Walde P; Voser M
Chem Biodivers; 2004 Jan; 1(1):65-97. PubMed ID: 17191776
[TBL] [Abstract][Full Text] [Related]
18. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
19. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
[TBL] [Abstract][Full Text] [Related]
20. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
